BTB Therapeutics
Monday, June 03, 2024
Pain Management
Company Presentation Theater 3
We are a clinical stage drug development company located in Kyoto, Japan. Our most advanced program is a non-opioid analgesic agent, ENDOPIN currently in phase 2a study.
Company Website:
https://btb-newdrug.co.jp/en/index.html
Lead Product in Development:
ENDOPIN, non-opioid analgesic
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Company HQ City
Kyoto
Company HQ State
Kyoto
Company HQ Country
Japan
CEO/Top Company Official
Tsuyoshi Ogiku, PhD, CEO
Development Phase of Primary Product
Phase II
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())